| Literature DB >> 32860883 |
Brighter Agyemang1, Wei-Ping Wu2, Michael Yelpengne Kpiebaareh2, Zhihua Lei2, Ebenezer Nanor2, Lei Chen3.
Abstract
The drug discovery stage is a vital aspect of the drug development process and forms part of the initial stages of the development pipeline. In recent times, machine learning-based methods are actively being used to model drug-target interactions for rational drug discovery due to the successful application of these methods in other domains. In machine learning approaches, the numerical representation of molecules is critical to the performance of the model. While significant progress has been made in molecular representation engineering, this has resulted in several descriptors for both targets and compounds. Also, the interpretability of model predictions is a vital feature that could have several pharmacological applications. In this study, we propose a self-attention-based multi-view representation learning approach for modeling drug-target interactions. We evaluated our approach using three benchmark kinase datasets and compared the proposed method to some baseline models. Our experimental results demonstrate the ability of our method to achieve competitive prediction performance and offer biologically plausible drug-target interaction interpretations.Keywords: Drug discovery; Drug–target interactions; Machine learning; Representation learning; Self-attention
Mesh:
Substances:
Year: 2020 PMID: 32860883 DOI: 10.1016/j.jbi.2020.103547
Source DB: PubMed Journal: J Biomed Inform ISSN: 1532-0464 Impact factor: 6.317